| Name | Title | Contact Details |
|---|
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Acumen is a Burlingame, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Echo, a HealthStream Company, is a combination of two industry leading software development companies, HealthLine Systems and Sy.Med Development. Echo develops and supports a comprehensive solution set for healthcare provider credentialing, privileging, enrollment, referral, onboarding, and analytics. Echo is supported by an industry leading development and client services staff with significant combined experience in the healthcare industry.
Caresyntax is on a mission to make surgery smarter and safer. Our enterprise-grade digital surgery platform delivers actionable insights to improve patient outcomes by using proprietary software and AI to analyze large volumes of video, audio, images, device data, clinical, and operational data in and around the OR.
Cangene BioPharma is a Baltimore, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.